MPA | Pharmacy News

By Gladys Dabaja, Pharm.D., director of pharmacy, Henry Ford Wyandotte Hospital, Wyandotte and SMSHP president-elect

The Southeastern Michigan Society of Health-System Pharmacists (SMSHP) continues to be busy with several continuing education (CE) programs during the third and fourth quarter of 2017. Our Board meetings resumed in September with a primary focus on upgrading and improving the SMSHP website. This will help promote membership growth and engagement as well as community outreach. The new website is more user friendly, and it will provide ease of service to our members. The Board has also been busy planning various events such as the Residency Showcase which was held on Oct. 11 at VisTaTech Center in Livonia. We had a great turnout and there was much enthusiasm among the students and program directors. Also, the Board has been working on finalizing the Annual Awards Banquet. General elections for president-elect, treasurer and two Board of Directors members were also held on Nov. 8.

SMSHP continues to host CE programs that are not only hot topics but relevant to society members. During our summer CE on Aug. 14, Margo Farber, Pharm.D., director of drug information services, University of Michigan Health-System, Ann Arbor, presented New Drug Approvals on Aug, 14. As always, Margo did a great job presenting new drug approvals that included their place in therapy. On Sept. 13, Janet Wu, Pharm.D., BCPS, clinical pharmacy specialist in infectious diseases at the Cleveland Clinic Foundation in Cleveland, Ohio, presented Updates to the IDSA HAP/VAP Guidelines. She did a thorough job of discussing current HAP and VAP guidelines as well as explaining the various studies related to empiric double coverage therapy. Janet was also the recipient of our Resident Award, and it was great to have her back to present. On Oct. 11, James Stevenson, Pharm.D., FASHP, professor of clinical pharmacy at the University of Michigan College Of Pharmacy, Ann Arbor, presented Considerations with the Adoption of Biosimilars. Jim explained the regulatory pathway in the U.S. for biosimilars as well as discussed Europe’s experience with these products. Additionally, he did a great job summarizing the implications for health systems utilizing biosimilars that include formulary considerations, product substitutions and transition of care. As we wind things down this year, we had our final CE presentation for 2017 on Nov. 8. David Frame, Pharm.D., hematology/immunohematology/BMT specialist at the University of Michigan, Ann Arbor, presented A New Era In Oncology: Immunotherapy. This is an area of pharmacy that continues to grow and evolve. 

As President of SMSHP for 2018, I look forward to continued work with our Board and Society members in the coming year. I am honored and thrilled to lead a professional organization that continues to grow and serve the interests of our members.

Bookmark and Share  

Search for
Pharmacy News